Our data analytics research has revealed that up to 25% of IVF patients discontinue treatment while they still have a good likelihood of success.
Our cost effectiveness studies have demonstrated that more than 90% of patients would benefit from initiating with IVF or moving to IVF faster after failed non-IVF treatments.
Our whole genome sequencing efforts have revealed common molecular pathways that are disrupted in patients struggling to have a baby.
Our large-scale, meta-analysis work has revealed patterns in fertility disorders, such as endometriosis, that were not detectable on a smaller scale.